Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
Allergy2024Vol. 79(6), pp. 1560–1572
Citations Over TimeTop 1% of 2024 papers
Emma Guttman‐Yassky, Kenji Kabashima, D. Staumont‐Sallé, Walter K. Nahm, Sylvia Pauser, Joel Corrêa da Rosa, Britta C. Martel, Daniel Elenius Madsen, Mads A. Røpke, Petra Arlert, Louise Abildgaard Steffensen, Andrew Blauvelt, Kristian Reich
Abstract
NCT03131648, NCT03587805.
Related Papers
- → Protein composition of cornified cell envelopes of epidermal keratinocytes(1994)251 cited
- → Biosynthetic pathways of filaggrin and loricrin—two major proteins expressed by terminally differentiated epidermal keratinocytes(1990)188 cited
- → The Expression of Involucrin, Loricrin, and Filaggrin in Cultured Sebocytes(2014)17 cited
- → Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis(2024)6 cited
- 건선 환자에서 involucrin , loricrin , filaggrin , bcl-2 의 발현에 관한 면역조직화학적 연구(2002)